Risky Business: Should the FDA Pay Attention to Pharmaceutical Prices?

SSRN Electronic Journal
doi 10.2139/ssrn.2970683
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Should I Pay for Your Risky Behaviours? Evidence From London

Preventive Medicine
EpidemiologyPublic HealthOccupational HealthEnvironmental
2014English

We Should Pay More Attention to Renal Function Before Initiation of Warfarin Therapy

Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Real Forensic Experts Should Pay More Attention to the Dangers Posed by ‘Ad Hoc Experts’

Australian Journal of Forensic Sciences
Forensic MedicinePathology
2017English

“Risky Business”

Feminist Media Studies
CommunicationGender StudiesPerforming ArtsVisual Arts
2013English

Risky Business

Contexts
2015English

Risky Business

Diabetes Educator
Health ProfessionsDiabetesMetabolismEndocrinology
2011English

Pay Attention to the Microbe Behind the Curtain

American Journal of Infection Control
EpidemiologyPublic HealthHealth PolicyInfectious DiseasesEnvironmentalOccupational Health
2015English

Risky Arbitrage, Asset Prices, and Externalities

Economic Theory
EconomicsEconometrics
2006English

Adapting to Climate Change: Who Should Pay?

SSRN Electronic Journal
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy